Document is current
Any future updates will be listed below
-
Authors
Starling, Amaal J. https://orcid.org/0000-0003-1334-1157
Buse, Dawn C. https://orcid.org/0000-0002-3784-6144
Cady, Roger https://orcid.org/0000-0003-4081-8395
Lenaburg, Kevin
Kymes, Steven https://orcid.org/0000-0003-4594-5617
-
Funding
Funding for this research was provided by:
Lundbeck LLC, Deerfield, IL, USA
- License Information
-
More Information
Article History
Received: 30 September 2024
Revised: 16 July 2025
Accepted: 17 July 2025
First Online: 6 August 2025
Declarations
:
: All participants in this Harris Poll survey were asked to read the Harris Poll privacy policy prior to agreeing to take the survey (). Only those who selected “I agree to continue” moved on to the screener section. Institutional review board approval was not conducted, as this survey was non-interventional in nature, was not intended to provide clinical data for treatment decisions, was not conducted as a clinical trial for any endpoints, and data are not identifiable in the results presented.
: In collaboration with the academic authors, the sponsor participated in the design and conduct of the survey and in the collection, management, analysis, and interpretation of the data. The preparation, review, and approval of the manuscript was undertaken by all authors and by a professional medical writer and editor funded by the sponsor.
: AJS has received consulting fees from AbbVie, Allergan, Axsome Therapeutics, eNeura Everyday Health, Lundbeck, Med-IQ, Medscape, Miller Medical, Satsuma, and WebMD. DCB has received grant support from the US Food and Drug Administration, and the National Headache Foundation; served as a consultant and received honoraria from Allergan/AbbVie, Amgen/Novartis, Biohaven, Collegium, Eli Lilly, Lundbeck, Theranica, Teva and Pfizer; and serves on the editorial board of Current Pain and Headache Reports. RC was an employee of Lundbeck LLC for the development and initiation of the survey and currently consults with Biohaven, Haleon, Lundbeck, and Axon. KL has received consulting fees from AbbVie, Allergan, Impel, and Lundbeck, during the development and fielding of the survey. He was an employee of the Coalition for Headache and Migraine Patients (CHAMP), an organization that receives sponsorship support from AbbVie, Amgen, Eli Lilly, Impel, Lundbeck, and Teva. He is a current employee of Psychedelics & Pain Association (Lombard, IL, USA). SK was an employee of Lundbeck LLC (Deerfield, IL, USA) at the time of this study.
